Nabriva Therapeutics plc (NBRV) Earnings
|
Expand Research on NBRV
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -12.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/10/23 | Q223 | N/A | -$2.30 | N/A | N/A | $17.4M | N/A | N/A | N/A | ||
| 5/29/23 | Q123 | N/A | -$3.37 | N/A | N/A | $12.9M | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | N/A | -$3.37 | N/A | N/A | $12.9M | N/A | N/A | N/A | ||
| 3/27/23 | Q422 | N/A | -$4.03 | N/A | N/A | $9.84M | N/A | N/A | N/A | ||
| 3/20/23 | Q422 | N/A | -$4.03 | N/A | N/A | $9.84M | N/A | N/A | N/A | ||
| 3/16/23 | Q422 | N/A | -$4.03 | N/A | N/A | $9.84M | N/A | N/A | N/A | ||
| 11/10/22 | Q322 | -$4.21 | -$4.03 | -$0.18 | $9.15M | $11.05M | N/A |  | | Details | |
| 8/3/22 | Q222 | -$0.29 | -$0.20 | -$0.09 | $8.24M | $8.53M | N/A | | | Details |
